Irish Employment Minister Billy Kelleher has officially opened a the new state-of-the-art manufacturing facility in Tipperary.
Plans for the Cashel-based development laboratory and finished goods testing facility were announced by Cordis Corporation in July 2006, and supported by IDA Ireland.
The new facility features some of the most advanced production equipment available globally, while the development laboratory will help to design and test future generations of manufacturing technology and drug-device products.
Minister Kelleher said: "This significant investment by Cordis re-affirms Ireland as a leading location for manufacturing and development of innovative healthcare products.
"I wish to congratulate Cordis for the speed with which this investment has developed. It is excellent news for Cashel and the surrounding region and will provide a substantial boost to the economy of the area."
Victor Chance, Vice President, Worldwide Operations, Cordis Corporation, said: "This facility represents our continued commitment to delivering innovative solutions that save lives."
The 180,000 square foot Cashel facility will produce Cordis' innovative, next-generation drug-eluting stent - known as the NEVO Sirolimus-eluting Coronary Stent.
(PR/JM)
Ireland
UK
Scotland
London











